A N D O

Can't Afford Cancer Treatment in the US? Every Option: Including the One Nobody Lists

Last updated: July 28, 2026 · This page lists the domestic options first, honestly, the abroad option earns its place at the end, with numbers.

Direct answer: Work the list in order: ①hospital charity care (nonprofit hospitals must have financial-assistance policies. Ask for the application, in writing) ②Medicaid/ACA (a diagnosis plus income change can qualify you mid-year) ③clinical trials ④drug-maker patient assistance ⑤nonprofit grants ⑥negotiated cash pricing, and then the option US resource lists never mention: ⑦treatment abroad, where three of the world's top-10 cancer hospitals (Seoul) publish their prices, and testing the fit costs ~$230 without leaving home.

The domestic list, honestly

OptionWhat it actually coversThe catch
Hospital financial assistance ("charity care")Nonprofit hospitals are required by federal tax law to maintain financial-assistance policies; bills can be reduced or written offYou must apply. It is almost never offered proactively. Ask before and after treatment; appeal denials
Medicaid / ACA marketplaceA diagnosis with reduced income can qualify you outside open enrollmentState-dependent; coverage gaps in non-expansion states
Clinical trialsSponsors typically cover the investigational care; often at top centersEligibility is narrow; routine-care costs may still bill to you
Manufacturer patient assistanceFree or reduced-cost drugs for qualifying patients, including many modern oncology drugsPaperwork-heavy; income thresholds
Nonprofit grants (CancerCare, PAN, HealthWell, ACS navigation)Co-pay and living-cost grants, transport, lodgingFunds open and close by cancer type; grants are capped
Cash-price negotiationItemized bills contain errors often enough to always request one; self-pay discounts of 20–50% are commonly negotiableYou are negotiating while sick, bring an advocate

The option the lists leave out

Run any US search on this question and count how many results mention treatment abroad: typically zero. Yet the arithmetic is checkable. Three of Newsweek's 2026 global top-10 cancer hospitals are in Seoul, Samsung Medical Center #3, Asan #4, SNUH #8, running the same protocols US centers use, with prices published rather than discovered on the final bill. Korea's cancer mortality is 64.3 per 100,000 vs 82.3 in the US.

The reversible way to test whether it changes your options: a written second opinion for ₩320,000 (~$230), the hospital's own published fee (Asan fee page), returned in English in 5–10 business days, records only, no travel. The same review runs $800–3,000 at US programs. If the verdict is "stay home," you've spent $230 to close the question. And if it isn't, you now have a real number to compare against your US bill before spending anything on travel.

Honest caveats

If you are well-insured, staying home often wins, out-of-pocket maximums exist precisely for this. The abroad math is strongest for the uninsured, the underinsured, and the denied.

Treatment abroad is a treatment decision, not just a financial one: being away from family during treatment has weight no price table captures. Start with the written opinion, it costs the least and moves nothing.

Beware anyone who quotes a package before seeing your records. Real programs read first, price second, and tell some patients not to come.

Related guides

Is treatment in Korea safe? · US vs Korea treatment costs · How the $230 second opinion works